Radiation Oncology Market Projected to Offer Substantial Growth Opportunities, Reaching $12.41 Billion by 2029
Grab 20% Off With Code ONLINE20 On Global market Reports – Evaluate Global Trends, Market Risks, and Competitive Intelligence
What Is the Comparative Market Size of the Radiation Oncology Market Between 2025 and 2029?
The radiation oncology market size has grown strongly in recent years. It will grow from $7.99 billion in 2024 to $8.73 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to rising cancer incidence, increased healthcare spending, growth in healthcare infrastructure investments, a rising aging population, and a rising prevalence of complex cancer cases.
The radiation oncology market size is expected to see strong growth in the next few years. It will grow to " $12.41 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to growing demand for precision treatments, expansion of outpatient cancer centers, increasing adoption of treatment planning software, increasing government initiatives in cancer care, and growing healthcare infrastructure. Major trends in the forecast period include personalized treatment plans, high-definition imaging, AI-powered imaging, stereotactic body radiation therapy (SBRT), and brachytherapy advancements.
Get your free report sample today:
What Are the Underlying Growth Drivers for the Radiation Oncology Market?
The growing number of cancer patients is expected to propel the growth of the radiation oncology market going forward. Cancer patients are individuals diagnosed with cancer, a disease characterized by the uncontrolled growth and spread of abnormal cells in the body. The increasing number of cancer patients is largely driven by the widespread adoption of unhealthy lifestyles, which significantly elevate cancer risks. Radiation oncology treats cancer by using high-energy radiation to destroy cancer cells, shrink tumors, relieve symptoms, and enhance the effectiveness of surgery and chemotherapy, with advanced techniques improving precision and outcomes. For instance, in October 2024, according to the National Health Service, a UK-based government department, there were 346,217 new cancer diagnoses in 2022, averaging 948 per day, up from 329,664 in 2021, marking a 5% increase. Therefore, the growing number of cancer patients is driving the growth of the radiation oncology market.
What Are the Major Segments Defining the Structure of the Radiation Oncology Market?
The radiation oncologymarket covered in this report is segmented –
1) By Type: External Beam Radiation Therapy; Internal Beam Radiation Therapy
2) By Application: Prostate Cancer; Breast Cancer; Lung Cancer; Head And Neck Cancer; Colorectal Cancer; Cervical Cancer; Gynecological Cancer; Other Applications
3) By End-User: Hospitals; Cancer Research Institutes; Other End-Users
Subsegments:
1) By Internal Beam Radiation Therapy; Brachytherapy; Endocavitary Brachytherapy; Interstitial Brachytherapy; Intraluminal Brachytherapy
2) By External Beam Radiation Therapy; 3D Conformal Radiation Therapy (3DCRT); Intensity-Modulated Radiation Therapy (IMRT); Stereotactic Radiosurgery (SRS); Stereotactic Body Radiation Therapy (SBRT); Image-Guided Radiation Therapy (IGRT)
Which Disruptive Trends Are Reshaping the Competitive Landscape of the Radiation Oncology Market?
Major companies operating in the radiation oncology market are focusing on developing advanced radiation therapy systems incorporating AI-powered imaging and adaptive technologies to enhance treatment precision, reduce side effects, and improve patient outcomes for diverse cancer treatment applications. AI-powered radiotherapy refers to the use of artificial intelligence technologies to enhance various aspects of radiation therapy, including treatment planning, imaging, delivery, and monitoring. For instance, in May 2024, Elekta, a Sweden-based medical technology company, launched Evo, its latest CT-Linac featuring high-definition AI-enhanced imaging designed to improve radiation therapy techniques. The versatile system supports offline and online adaptive radiation therapy along with enhanced standard image-guided radiation therapy, providing clinicians with greater precision and flexibility to tailor treatments for individual patients. This innovation aims to enhance patient outcomes by optimizing treatment accuracy and adaptability.
Which Firms Represent the Competitive Benchmark Within the Radiation Oncology Market?
Major companies operating in the radiation oncology market are Hitachi Ltd., Siemens Healthineers, Philips Healthcare, GE Healthcare Technologies Inc., Varian Medical Systems, Shimadzu Corporation, Elekta AB, Mirion Technologies, Ion Beam Applications (IBA), Accuray Incorporated, Canon Medical Systems, Eckert & Ziegler BEBIG, ViewRay Inc., MDS Nordion, Mevion Medical Systems, PTW-Freiburg, Toshiba Medical Systems, CivaTech Oncology, ProTom International, Radcal Corporation, ScandiDos.
Get the detailed radiation oncology market report today
Which Regions Are Driving the Highest Demand in the Radiation Oncology Market?
North America was the largest region in the radiation oncology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the radiation oncology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
Comments
Post a Comment